SANTA CLARA, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- OmicInsight Corporation, an innovator in ...
The market is fueled by the technology’s ability to map biomolecules and cellular interactions within tissues, enabling ...
Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx, Inc.
Psomagen, a recognized leader in servicing academic and commercial clients, will serve as a partner, introduce OmicInsight’s specialized spatial transcriptomics services to its extensive network ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results